These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15793188)

  • 21. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention.
    Corpus RA; George PB; House JA; Dixon SR; Ajluni SC; Devlin WH; Timmis GC; Balasubramaniam M; O'Neill WW
    J Am Coll Cardiol; 2004 Jan; 43(1):8-14. PubMed ID: 14715174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention.
    Cho L; Lewis BE; Steen LH; Leya FS
    Cardiology; 2005; 104(2):97-100. PubMed ID: 16020949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and predictors of target vessel revascularization after sirolimus-eluting stent treatment for proximal left anterior descending artery stenoses among 2274 patients from the prospective multicenter German Cypher Stent Registry.
    Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Sabin G; Tebbe U; Schneider S; Richardt G;
    Clin Res Cardiol; 2007 May; 96(5):279-84. PubMed ID: 17323010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
    Singh M; Williams BA; Gersh BJ; McClelland RL; Ho KK; Willerson JT; Penny WF; Cutlip DE; Holmes DR
    J Am Coll Cardiol; 2006 Jan; 47(1):34-9. PubMed ID: 16386661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization.
    Jackson JD; Muhlestein JB; Bunch TJ; Bair TL; Horne BD; Madsen TE; Lappé JM; Anderson JL;
    Am Heart J; 2003 May; 145(5):875-81. PubMed ID: 12766747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
    Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
    JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.
    West NE; Ruygrok PN; Disco CM; Webster MW; Lindeboom WK; O'Neill WW; Mercado NF; Serruys PW
    Circulation; 2004 Feb; 109(7):867-73. PubMed ID: 14757691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a risk score for target vessel revascularization after coronary stent implantation.
    Quadros AS; Diemer F; Welter D; Modkovski T; Sarmento-Leite R; Gottschall CA
    J Invasive Cardiol; 2009 Dec; 21(12):618-22. PubMed ID: 19966362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic.
    Prasad A; Rihal CS; Lennon RJ; Wiste HJ; Singh M; Holmes DR
    J Am Coll Cardiol; 2007 Apr; 49(15):1611-1618. PubMed ID: 17433951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.
    Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART).
    Mauri L; Reisman M; Buchbinder M; Popma JJ; Sharma SK; Cutlip DE; Ho KK; Prpic R; Zimetbaum PJ; Kuntz RE
    Am Heart J; 2003 May; 145(5):847-54. PubMed ID: 12766743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.
    Hoffmann R; Stellbrink E; Schröder J; Grawe A; Vogel G; Blindt R; Kelm M; Radke PW
    Am J Cardiol; 2007 Nov; 100(9):1347-52. PubMed ID: 17950788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of asymptomatic restenosis in patients with first anterior ST elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Wita K; Kinasz L; Filipecki A; Lelek M; Szczogiel J; Turski M; Weglarz P; Elzbieciak M; Staroń A; Trusz-Gluza M
    Kardiol Pol; 2010 Sep; 68(9):987-93. PubMed ID: 20859886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
    Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
    J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.